• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Effects of advanced glycation endproducts on vascular permeability and vascular cell adhesions.

Research Project

Project/Area Number 10672158
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionTokyo Women's Medical University

Principal Investigator

MURAKI Takamura  Tokyo Women's Medical University, School of Medicine, Professor, 医学部, 教授 (50051446)

Co-Investigator(Kenkyū-buntansha) IRIE Kaoru  Tokyo Women's Medical University, School of Medicine, Research Associate, 医学部, 助手 (50075496)
FUJII Emiko  Tokyo Women's Medical University, School of Medicine, Associate Professor, 医学部, 助教授 (20075493)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 1999: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1998: ¥2,700,000 (Direct Cost: ¥2,700,000)
Keywordsadvanced glycation endproducts / streptozotocin-diabetic mice / plasma extravasation / platelet activating factor / plasminogen activator inhibitor-1 / gene expression / endothelial cells / white adipocyte / 糖化最終産物 / 血管透過性 / 内皮細胞 / ストレプトゾトシン / セロトニン
Research Abstract

Hyperglycemia followed by the formation of advanced glycation endproducts (AGEs) is considered to be the major cause of vascular complications associated with diabetes. The following studies were performed to investigate the possible role of AGEs in the pathogenesis of diabetic vascular complications.
1). The effect of diabetes on plasma extravasation induced by proinflammatory agents was investigated in streptozotocin (STZ)-diabetic mice 2 weeka after STZ (170 mg/kg ip), using dye leakage method. The platelet activating factor (PAF)-induced increase in vascular permeability was inhibited in the STZ-diabetes mice. Normalization of blood glucose by insulin treatment restored the PAF-induced vascular peameability response to the level of normal controls. Aminoguanidine treatment, which is proposed to prevent the AGE formation, did not reverse the diminished response to PAF in the STZ-diabetic mice.
2). The effects of AGE-BSA and 3-deoxyglucoson (3-DG), an eary glycation product, were studied on various function of inflammatory cells, including albumin peameability through the monolayer of bovine endothelial cells, adhesion of monocytes on the human umbilical vein endothelial cells (HUVECs) and the chemotaxis of rat smooth muscle cells. These functions of cultured cells were not affected by incubation with 3-DG or AGE-BSA. When HUVECs were cultured in g;lycated collagen-coated dishes, cell proliferation was reduced.
3). The mRNA expression of plasminogen activator inhibitor (PAI)-1 was examined in cultured rat white adipocytes by northern blot analysis. AGE-BSA increased the PAI-1 mRNA abundance in white adipocytes concentration-dependently. Increase in blood PAI-1 induces thrombosis, thereby may cause the vascular complications in diabetes.
4). Although AGEs have significant effects on adipocytes, they did not disrupt the integrity of cultured endothelial cells.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] 藤井惠美子 他: "Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice"Microvascular Res. 58. 74-78 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 藤井惠美子 他: "Role of endogenous nitric oxide in the nitric oxide donor-induced plasma extravasation of mouse skin"Europ J Pharmacol. 377. 219-222 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 藤井惠美子 他: "エンドトキシンおよびリポタイコ酸によるマウス皮膚炎症反応の比較"臨床薬理. 29(1・2). 137-138 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 藤井惠美子 他: "エンドトキシン前処置によって惹起されるマウス皮膚血管透過性抑制作用"炎症. 18(4). 301-304 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 村木篁 他: "Impaired response of dermal microvessels to platelet activating factor(PAF)in streptozotocin-diabetic mice"Naunyn-Schimied Arch Pharmacol. 358(1)(Suppl2). R552 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 藤井惠美子 他: "Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide"Br J Pharmacol. (印刷中). (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 藤井惠美子 他: "エンドトキシン研究1"日本エンドトキシン研究会. 228 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] FUJII,Emiko, YOSHIOKA Toshimasa, WADA,Keiji, ISHIDA,Hiroyasu, IRIE,Kaoru & MURAKI,Takamura: "Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice"Microvascular Res.. 58. 74-78 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] FUJII,Emiko, WADA,Keiji, ISHIDA,Hiroyasu, YOSHIOKA,Toshimasa & MURAKI,Takamura: "Role of endogenous nitric oxide in the nitric oxide donor-induced plasma extravasation of mouse skin"Europ J Pharmacol. 377. 219-222 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] FUJII,Emiko, YOSHIOKA,Toshimasa, ISHIDA,Hiroyasu, IRIE,Kaoru & MURAKI,Takamura: "Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide"Br J Pharmacol. 2000, in press.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] FUJII,Emiko, WADA,Keiji & MURAKI,Takamura: "Endotoxin-induced desensitization for mouse dermal vascular permeability"Jan J Inflammation. 18. 301-304 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] MURAKI,Takamura, FUJII,Emiko, WADA Keiji & YOSHIDA,Toshimasa: "Impaired response of dermal microvessels to platelet activating factor (PAF) in streptozolocin-diabetic mice"Naunyn-Schimied Arch Phammacol. 358(1) (Suppl 2). R552 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] FUJII,Emiko, WADA,Keiji, IRIE,Kaoru, YOSHIOKA,Toshimasa, URAKAWA,Ikuko & MURAKI,Takamura: "Inhibition by adenosine 3', 5' cyclic monophosphate (cAMP) of lipopolysaccharide (LPS)-induced increase in mouse dermal microvascular permeability"Naunyn-Schimied Arch Pharmacol. 358(1) (Suppl 2). R73 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 藤井惠美子他: "Microvasxular pemeability change induced by platelet-actibating factor is impaired in diabetic mice"Microvascular Res. 58. 74-78 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 藤井惠美子他: "Role of endogenous nitric oxide in nitric oxide donor-induced plasma extravasation of mouse skin"Europ J Pharmacol. 377. 219-222 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 藤井惠美子他: "エンドキシンおよびリポタイコ酸によるマウス皮膚炎症反応の比較"臨床薬理. 29(1・2). 137-138 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] 藤井惠美子他: "エンドキシン前処理によって惹起されるマウス皮膚血管透過世抑制作用"炎症. 18(4). 301-304 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] 村木篁他: "Impaired response of demal microbessels to plateler activating factor(PAF)in streptozotocin-diabetic mice"Naunyn-Schimied Arch Phamacol. 358(1)(Suppl 2). R552 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] 藤井惠美子他: "Evaluation of iNOS-dependent and independent mechanisms of the microvascular pemeability change induced lipoplysacchride"Br J Pharmacol. (印刷中). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] 藤井惠美子他: "エンドトキシン研究1"日本エンドトキシン研究会. 228 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Emiko FUJII: "Suppressive effects of phosphodiesterase(PDE)inhibitors and β-adrenoceptor agonists on the dermal vascular permeability change induced by lipopolysaccharide(LPS)in mice." Jpn.J.Pharmacol.76 Suppl I. 160p (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Emiko FUJII: "Inducible nitric oxide synthase(iNOS)-deficient mice show altered dermal vascular permeability elicited by lipopolysaccharide." Jpn.J.Pharmacol.76 Suppl I. 62p (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Takamura MURAKI: "Impaired response of dermal microvessels to platelet activating factor(PAF)in streptozotocindiabetic mice." Naunyn-Schmied Arch Pharmacol. 358(1) Suppl II. R552 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Emiko FUJII: "Inhibition by adenosine 3',5'cyclic monophosphate(cAMP)of lipopolysaccharide(LPS)-induced increase in mouse dermal microvascular permeability." Naunyn-Schmied Arch Pharmacol. 358(1) Suppl II. R737 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 藤井恵美子: "エンドトキシン前処置によって惹起されるマウス皮膚血管透過性抑制作用" 炎症. 18(4). 301-304 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 藤井恵美子: "エンドトキシン研究1 基礎と臨床" 菜根出版, 228(155-159) (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi